Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.
作者信息
Hyak Jonathan M, Huang Ying, Rogers Kerry A, Bhat Seema A, Grever Michael R, Byrd John C, Kittai Adam S, Jones Dan, Miller Cecelia R, Woyach Jennifer A
机构信息
Department of Medicine and Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Department of Pathology, The Ohio State University Comprehensive Cancer Center, Columbus, OH; and.
出版信息
Blood Adv. 2022 Sep 13;6(17):5124-5127. doi: 10.1182/bloodadvances.2022007708.
Abstract
摘要
Zotero 插件